[Skip to Navigation]
Sign In
January 2005

Pityrosporum Folliculitis: Diagnosis and Management in 6 Female Adolescents With Acne Vulgaris

Author Affiliations

Author Affiliations: Division of Dermatology, Departments of Medicine (Drs Sweeney and Wiss) and Pediatrics (Drs Sweeney and Wiss), University of Massachusetts Medical School (Ms Ayers), Worcester.

Arch Pediatr Adolesc Med. 2005;159(1):64-67. doi:10.1001/archpedi.159.1.64

Background  Pityrosporum folliculitis is a common inflammatory skin disorder that may mimic acne vulgaris. Some adolescents with recalcitrant follicular pustules or papules may have acne and Pityrosporum folliculitis simultaneously. Clinical response is dependent on treating both conditions.

Objectives  To demonstrate the similarity in clinical manifestation between acne vulgaris and Pityrosporum folliculitis, the benefit of potassium hydroxide preparation, and the benefit of appropriate antifungal therapy.

Patients  We describe 6 female adolescents with concurrent Pityrosporum folliculitis infection and acne vulgaris.

Intervention  A potassium hydroxide examination was performed on all 6 patients from the exudate of follicular pustules exhibiting spores consistent with yeast. All patients were treated with oral antifungals, and 5 of the 6 patients were also treated with topical antifungals.

Results  Six of 6 patients improved with antifungal treatment. All patients also required some ongoing therapy for their acne.

Conclusions  These patients demonstrate that follicular papulopustular inflammation of the face, back, and chest may be due to a combination of acne vulgaris and Pityrosporum folliculitis, a common yet less frequently identified disorder. Symptoms often wax and wane depending on the patient’s activities, time of the year, current treatment regimens, and other factors. Pityrosporum folliculitis will often worsen with traditional acne therapy and dramatically respond to antifungal therapy.

Pityrosporum folliculitis was first described in 1969 by Weary et al1 and noted to be an acneiform eruption associated with antibiotic use. It is an infection of the hair follicle thought to be caused by the common cutaneous yeast, Malassezia furfur (Pityrosporum ovale) and possibly other strains of Malassezia.2-4Malassezia is a dimorphic lipophilic yeast that can be found in small numbers in the stratum corneum and hair follicles of up to 90% of individuals without disease.2-4 Some individuals colonized with Malassezia develop folliculitis, while others develop tinea versicolor and seborrheic dermatitis.5,6 The papulopustular folliculitis is most commonly found on the chest, back, upper arms, and less frequently on the face. Often it is misdiagnosed as acne.6,7

Pityrosporum folliculitis typically appears as 1- to 2-mm pruritic, monomorphic, pink papules and pustules. Positive potassium hydroxide (KOH) examination results showing numerous spores and other yeast forms support the diagnosis. It may be difficult to distinguish clinically from acne vulgaris. Traditional acne therapies, especially antibiotics, worsen Pityrosporum folliculitis. We discuss 6 patients with recalcitrant “acne” who had acne vulgaris and Pityrosporum folliculitis simultaneously.


All patients were seen in the general pediatric dermatology clinics at University of Massachusetts Memorial Health Care, Worcester, as part of routine clinic visits. The University of Massachusetts Medical School institutional review board was notified of this retrospective case review study and granted approval without full committee review.


All 6 of the patients seen at University of Massachusetts Memorial dermatology clinics were adolescent white girls with a history of pruritic papules and pustules on the face, chest, and/or back (Table). The patients had limited responses to traditional acne therapies and recent exacerbation of their symptoms. In addition to the traditional inflammatory papules, pustules, and comedones of acne vulgaris, these patients also displayed uniform 1- to 2-mm monomorphic, erythematous papules and pustules (Figure 1 and Figure 2) that were pruritic during hot, humid weather and increased activity. A KOH examination on scrapings of the monomorphic pustules revealed spores and budding yeast forms consistent with Pityrosporum folliculitis in all 6 patients. They were diagnosed with Pityrosporum folliculitis in addition to acne vulgaris. Any oral antibiotics that were being used at the time of diagnosis were discontinued. Six of 6 patients responded well to a combination of topical and oral antifungal treatment. Four of the 6 patients experienced flares of symptoms especially during hot and humid weather requiring intermittent treatment with both oral and topical antifungals. The patients were also treated with topical or oral medications for their acne vulgaris, but antibiotics, especially oral antibiotics, were used sparingly and only when necessary.

Figure 1. 
A 15-year-old girl with 1- to 2-mm erythematous papules and pustules of Pityrosporum folliculitis.

A 15-year-old girl with 1- to 2-mm erythematous papules and pustules of Pityrosporum folliculitis.

Figure 2. 
Close-up view of the same patient showing multiple tiny pustules.

Close-up view of the same patient showing multiple tiny pustules.

Clinical Characteristics and Treatment of 6 Patients With Concurrent Pityrosporum Folliculitis and Acne Vulgaris
Clinical Characteristics and Treatment of 6 Patients With Concurrent Pityrosporum Folliculitis and Acne Vulgaris


Pityrosporum folliculitis may be underdiagnosed because it can mimic acne vulgaris. Typical patients will not respond to or only partially respond to topical and oral antibiotics, topical retinoids, and other acne treatments. A KOH examination is an easy, inexpensive, and accessible method of immediately clarifying the diagnosis.

The pathophysiologic features of Pityrosporum folliculitis involve follicular occlusion followed by an overgrowth of yeast that thrives in a sebaceous environment.3,7 Altered host immunity is also thought to play a role in Pityrosporum folliculitis because 90% of people have Malassezia as a part of their normal skin flora without signs and symptoms of folliculitis or other disease.2,4 Furthermore, Pityrosporum folliculitis is associated with the use of oral corticosteroids, diabetes mellitus, organ transplantation, chemotherapy, and other immunosuppressed states.8,9

Pityrosporum folliculitis is commonly found in adolescents presumably because of the increased activity of their sebaceous glands. Some colonized individuals develop tinea versicolor, and others develop Pityrosporum folliculitis. Perhaps the density of lipids in the pilosebaceous unit of acne-prone individuals leads to a higher concentration of the organism in hair follicles and thus a folliculitis. All of our patients were female, and some other studies also report increased incidence among girls. However, a predominance in boys and equal sex distribution have also been described.5,7 In our patients, the female predominance may reflect a referral bias of girls to female physicians. Pityrosporum folliculitis is also more common in hot and humid climates.5,8 Four of our 6 patients had flares during hot, humid weather and with increased episodes of sweating.

Given the role of follicular plugging, it is no surprise that our patients had a combination of acne and Pityrosporum folliculitis. Treatment regimens that address both of these conditions are necessary for improvement. Antibiotics commonly used to treat acne may suppress normal bacterial flora and allow overgrowth of Malassezia. This may explain some cases of what appears to be persistent acne that shows no improvement and actually worsens with oral antibiotic treatment as seen in patient 4.

In treating recalcitrant acne complicated by Pityrosporum folliculitis, host response plays a significant role in determining whether a patient may be able to permanently eradicate the yeast colonization. Patients may require prophylaxis or retreatment (ie, antifungal shampoos and/or pulse dosing of oral antifungals), especially during times in which they are prone to breakouts. Five of our 6 patients who responded to oral antifungal treatment also required maintenance with ketoconazole shampoo or selenium sulfide shampoo. In addition, 3 of these 6 patients required multiple courses of oral antifungals.

Pityrosporum folliculitis usually responds well to oral antifungal medications. Topical antifungals are less useful in the initial treatment of Pityrosporum folliculitis but are important in maintenance and prophylaxis. The discontinuation of oral and topical antibiotics is also useful when treating Pityrosporum folliculitis. Furthermore, one is able to get a clearer picture of the extent of the acne once the folliculitis is treated if some or all of acne medications are discontinued prior to the initiation of antifungal treatment.

A KOH mount can be prepared by gently scraping 1 of the monomorphic pustules with a sterile scalpel blade, smearing the pustular contents on a glass slide, and treating it with 1 to 2 drops of 10% KOH and a coverslip. The slide can then be examined under the microscope for spores. This allows for a more immediate diagnosis than either skin biopsy or culture.6 Cultures of Malassezia are rarely required for diagnosis and are complicated by the yeast’s special culture-medium requirements. Malassezia grows only within a medium rich in C12, C13, and C14 fatty acids, which can be achieved by adding olive oil to the medium.9

These patients were described with the goal of encouraging physicians to have a high suspicion for Pityrosporum folliculitis in adolescent patients with recalcitrant acne. We also advocate performing a KOH preparation in any patient with monomorphic or acneiform pustules on the scalp, trunk, or upper extremities who is not responding to or worsening with antibiotics. There is no one specific treatment regimen that can be suggested to eradicate both acne vulgaris and Pityrosporum folliculitis. Therefore, close patient follow-up to monitor response to therapy is important. Our patients responded well to oral ketoconazole or fluconazole. Patients must be advised of potential adverse effects of ketoconazole and other antifungals including nausea, vomiting, diarrhea, abdominal pain, and hepatotoxicity. Liver function should be evaluated in patients on long courses or multiple courses of oral ketoconazole.

Correspondence: Karen Wiss, MD, Pediatric Dermatology, University of Massachusetts Medical School, Hahnemann Campus, 281 Lincoln St, Worcester, MA 01605 (wissk@ummhc.org).

Back to top
Article Information

Accepted for Publication: August 19, 2004.

Weary  PERussell  CMButler  HKHsu  YT Acneform eruption resulting from antibiotic administration.  Arch Dermatol 1969;100179- 183PubMedGoogle ScholarCrossref
Faergemann  JJohansson  SBäck  OScheynius  A An immunologic and cultural study of Pityrosporum folliculitis.  J Am Acad Dermatol 1986;14429- 433PubMedGoogle ScholarCrossref
Hill  MKGoodfield  MJRodgers  FGCrowley  JLSaihan  EM Skin surface electron microscopy in Pityrosporum folliculitis: the role of follicular occlusion in disease and the response to oral ketoconazole.  Arch Dermatol 1990;1261071- 1074PubMedGoogle ScholarCrossref
Roberts  SO Pityrosporum orbiculare: incidence and distribution on clinically normal skin.  Br J Dermatol 1969;81264- 269PubMedGoogle ScholarCrossref
Bäck  OFaergemann  JHörnqvist  R Pityrosporum folliculitis: a common disease of the young and middle aged.  J Am Acad Dermatol 1985;1256- 61PubMedGoogle ScholarCrossref
Yu  HJLee  SKSon  SJKim  YSYang  HYKim  JH Steroid acne vs Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne.  Int J Dermatol 1998;37772- 777PubMedGoogle ScholarCrossref
Abdel-Razek  MFadaly  GAbdel-Raheim  MAl-Morsy  F Pityrosporum (Malassezia) folliculitis in Saudi Arabia: diagnosis and therapeutic trials.  Clin Exp Dermatol 1995;20406- 409PubMedGoogle ScholarCrossref
Alves  EVMartins  JERibeiro  EBSotto  MN Pityrosporum folliculitis: renal transplantation case report.  J Dermatol 2000;2749- 51PubMedGoogle Scholar
Rupke  SJ Fungal skin disorders.  Prim Care 2000;27407- 421PubMedGoogle ScholarCrossref